N/A
Completed N=1,001
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Source: ClinicalTrials.gov NCT01294228 ↗Enrolled (actual)
1,001
Serious AEs
0.0%
Results posted
Feb 2017
Primary outcomePrimary: The Efficacy of the Triage Neutraphil-Gelatinase Associated Lipocalin (NGAL) Test as an Aid in the Diagnosis of Acute Kidney Injury (AKI) in an All-comers ICU Setting. — 0.671 Probability
Summary
This is a multi-center, prospective, observational study of patients that are admitted to the intensive care unit (ICU). This study does not include any treatment or intervention and it is considered Nonsignificant Risk.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY The Efficacy of the Triage Neutraphil-Gelatinase Associated Lipocalin (NGAL) Test as an Aid in the Diagnosis of Acute Kidney Injury (AKI) in an All-comers ICU Setting. |
0.671 | — |
Eligibility Criteria
Inclusion Criteria
- Subjects must be 21 years of age or older.
- Subjects must be admitted to an Intensive Care Unit (medical or surgical) and must be enrolled into this study within 12 hours of receipt of ICU admission orders.
- Subjects must be assessed as likely to be alive in the ICU for a minimum of 48 hours after enrollment.
- The following plasma/serum creatinine values must be available:
- Subjects that are admitted to the ICU following an elective surgery or procedure must have at least one pre-surgical/ pre-procedure creatinine value obtained in the 7 days prior to presentation to the ICU.
- Subjects that are admitted to the ICU for any reason other than following an elective surgery or procedure must have at least one creatinine value obtained greater than 7 days and up to 6 months prior to presentation to the ICU.
Exclusion Criteria
- Subjects either receiving or in imminent need of Renal Replacement Therapy.
- Subjects with evidence of chronic kidney disease stages 4 and 5 as evidenced by a pre-enrollment estimated GFR of less than 30 mL/min/1.73M2 (according to the 4-variable MDRD22).
- Subjects with any obstructive uropathy at the time of presentation to the ICU.
- Subjects with any known urothelial, urological or kidney malignancies.
- Subjects that have had any urologic procedure or surgery immediately prior to admission to the ICU.
- Subjects that have had any renal transplant or nephrectomy.
- Subjects that have had cardiovascular surgery involving cardiopulmonary bypass within the previous 7 days.
- Subjects that have participated in an interventional clinical study within the previous 30 days including studies with any investigational and non-investigational drugs.
- The inability to obtain written Informed Consent from the subject or an authorized representative.
- Subjects that have been previously enrolled in this study during a prior admission to the ICU.
Data sourced from ClinicalTrials.gov (NCT01294228). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.